|
22 Octobre 2008 |
|
There are no translations available.
Unfortunately, Europe is now publishing concerns stating there is substantial barriers to the diagnosis and effective management of ADHD states an article by Lilly (a Pharmeceutical Co. which produces drugs for depression, schizophrenia, diabetes, cancer, osteoporosis and many other diseases) Whereas the U.S. has held the number one place for diagnosis and prescribing for ADHD, Europe may soon become a close runner up. One news article in the U.K.., “ Parents may face jail over compulsory drug orders,” reveals a new fear tactic underway.
|
Wellness Research 
